Cibc Private Wealth Group, LLC Repligen Corp Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 80 shares of RGEN stock, worth $12,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 94
14.89%
Holding current value
$12,058
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.08 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$769 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$255 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$233 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.36B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....